Protein complexes

From GO Wiki
Revision as of 23:54, 12 May 2015 by Bmeldal (talk | contribs)

Jump to: navigation, search
  • NOTE: This is a work in progress. It needs to be wrapped up, and revised by editors, Becky and Birgit. Also, we need to add examples - what works and what doesn't.
  • Last updated: 13/5/2015, Birgit Meldal


Background and rationale

Recently, GO and IntAct have started to work together to improve the 'protein complex' branch in GO, making it less flat and more informative, and to provide species-agnostic GO terms that IntAct can reference to for their species-specific curation projects. At the time of writing the focus lies on human, mouse, yeast and E.coli but we take direct curation requests as well (intact-help@ebi.ac.uk). We'd like more MODs to collaborate directly.

Here, we collect current guidelines on protein complex terms, to aid GO curators in discerning whether a protein complex belongs in GO or not, and if yes, in including all necessary information when requesting a new protein complex.

Protein complexes in GO

Rule 1: Is the complex stable?

From the Complex Portal Rules http://www.ebi.ac.uk/intact/complex/documentation/

What can be described as a complex?

A stable set of (two or more) interacting macromolecules such as proteins which can be co-purified by an acceptable method and have been shown to exist as an isolated, functional unit in vivo. Any interacting non-protein molecules (e.g. small molecules, nucleic acids) will also be included.

What should not be captured:
  • Enzyme/substrate, receptor/ligand or any similar transient interactions unless these are a critical part of the complex assembly (e.g. PDGF receptors only become 'dimeric' when linked by the dimeric ligand forming a tetramer).
  • Proteins associated in a pulldown/coimmunoprecipitation with no functional link or any evidence that this is a defined biological entity rather than a loose affinity complex.
  • Any literature complex where the only evidence is based on genetic interaction data.
  • Partial complexes

Note:

  • If the complex is not stable, it's just protein binding. Interactions can then be captured by a protein-protein interaction DB such as IntAct.
  • Beware of partial complexes shown experimentally, especially when crystallised. Some subunits (e.g. transmembrane subunits) cannot be expressed as recombinant proteins and are 'left out' of detailed studies. More reading is often necessary to find out what the full complex is thought to be.
Tricky cases we DO (or could) capture in The Complex Portal:
  • Substrates or ligands if the enzyme or receptor complex only forms in their presence (see PDGF receptors above, e.g. EBI-9082861). These terms would also qualify for GO.
  • Homologous proteins, with the same functionality, which would be inferred by sequence similarity to form a complex but for which no physical link has been demonstrated, e.g. proteins A and B have been shown to physically interact and form a functional complex, protein C is a homologue of protein B by sequence similarity and is know to have the same function as B but protein A-C interaction has not been demonstrated experimentally. E.g. SUMO - E1 ligase complexes where there is interaction evidence for binding with SUMO1 (EBI-9349603) but not with SUMO2 (EBI-9345927).
  • The Complex Portal could also hold transient complexes, e.g. signaling complexes. We have not created any of these to date but they are possible, and CV terms exist to distinguish the two classes. BUT - they would probably fall outside the scope of GO if GO limit themselves to stable complexes.
  • We can also curate complexes that lack full experimental evidence but are commonly regarded as existing, e.g. complexes submitted by ChEMBL for which we only have pharmacological evidence. These complexes are tagged with ECO:0000306 - inferred from background scientific knowledge by manual assertion. E.g GABA (EBI-9008426) receptors and many other transmembrane receptors.

[Paola to add the 'stable complex' section as a def comment to 'protein complex'. Sent to go-consortium list on 28/4/15 for discussion.] [edited again by Birgit after GO annotation call on 12/5/15]

Rule 2: Is the complex species-agnostic?

  • GO should host species-agnostic complexes, ideally conserved across taxa. Where this isn't known, still make the def generic, and add 'For example, in human this complex contains...' as a def gloss or def comment.
  • Species-specific complexes don't belong in GO, but IntAct/Complex Portal and/or PRO can take them. [But we have a lot of historic terms that contravene this rule.]
  • We may, however, need taxon restrictions on a case by case basis such as complexes that only exist in prokaryots or eukaryotes.

Rule 3: Does the complex have a molecular function?

  • Ideally, add capable_of function links. These links are used by the reasoner to place the complex into the correct branch under 'protein complex'.

Rule 4: Is the complex known to be involved in one or more biological processes?

  • If yes, add capable_of_part_of process links.
  • Note: we decided not to use BP as a qualifier for making group terms for complexes as these would become too unspecific, e.g. 'regulatory complex' could include most complexes!

Rule 5: Does the complex contain conserved subunits?

  • GO does host complexes based on their subunits only, when no function or process information is available.
  • Most complexes contain some wording such as: "In human, it is composed of..." BUT, this is getting messy where subunit composition is different in different branches of the tree of life and different groups/MODs add their own examples. Should these just go in as NARROW synonyms? [to be discussed]
  • Complexes defined by their subunits but functionally identical to a more generic parent term should not be created as separate GO terms but added to the parent term as synonyms. The specific complex belongs in the Complex Portal.

[DOS to look into some automatic reasoning across subunits but we think it may become tricky. To be discussed on Editor's call.]

Rule 6: Where is the complex located?

  • Indicate cellular location as specifically as possible, unless parent already has one.
  • The CC is for the complex as a whole. We discussed this in the context of transmembrane complexes with members that are only located on one side of the membrane or have no membrane attachment at all. As gene products have the part_of relationship with the complexes this is fine (and the only way of reflecting the CC for the complex as a whole).
  • If we have complexes defined by their location (see below under 'Futures Plans'), does the reasoner take the part_of relationship to place them automatically into the right complex-by-location branch? [DOS?]

Rule 7: Adding appropriate is_a relationships

  • We are trying to avoid placing complexes as direct is_a children of 'protein complex' but add some granularity to the ontology.
  • An is_a parent of a complex can be a
  1. complex defined by its activity, via the complex-by-activity TG template
  2. complex defined by its location, such as 'plasma membrane complex'. [Can we have a complex-by-location template?]
  3. complex defined by its subunit composition. This may be related to protein families but it may be difficult to make it a rule/template (see below)
  • We decided to NOT define complexes by their process or MF binding as they would become too generic.
  • Note: Complexes can have multiple parents!

Rule 8: Adding appropriate part_of relationships

  • All complexes should have a part_of link to a cellular component, even if it's very generic, such as 'cell'.
  • CC does not have to be added manually if it's the same as the parent term as it will be inferred.
  • If the CC is more specific than the parent the part_of relationship must be added manually.
  • Complexes can be subcomplexes of larger entities and can therefore be part_of another protein complex.
  • Complexes cannot have several part_of relationships to different CCs as part_of must ALWAYS be true. If a complex can be part of several larger complexes or be found in several locations, such as cytoplasm and nucleus where it may have different functions, separate terms may have to be considered. [This point is still open to discussion, see https://sourceforge.net/p/geneontology/ontology-requests/10745/, now with DOS. To be discussed on Editor's call.]

How to request protein complexes in GO based on the above (TG template, TG freeform)

  • If the complex is generic and its function exists as a GO term, use the complex-by-activity template (and add relevant synonyms as discussed above).
  • If the function does not yet exist in GO but is clearly defined, create the new MF term first (via SF or TG FF depending on the curator's experience), then create the CC term for the complex via the template.
  • If the complex-by-activity template is not applicable, create the complex term either via SF or TG FF depending on the curator's experience.
  • IntAct is happy to curate requested complexes into the Complex Portal at the same time as adding to the GO structure. Curators are encouraged to curate complexes directly into the Complex Portal after being trained by IntAct. SGD are doing this already. Contact intact-help@ebi.ac.uk for either use case.

Complex Definition field

We discussed the structure of the definition as there are lots of different ways to build it. At the moment, Birgit starts with the function (if applicable), such as 'A protein complex capable of X function...'. Most defs contain examples of subunits but see above for difficulties. Other complex defs start with the list of subunits. We need to come up with a set of rules that suit most cases. Processes can also be mentioned in the def.

Complexes should NOT be defined by their stoichiometry but it may be mentioned in the def as a 'soft' comment. The problem is that, as knowledge advances and more examples are found, stoichiometry defs have to be updated, causing a lot of work. It is perfectly fine though to mention something like 'usually consists of a catalytic and a regulatory subunit and possibly further accessory subunits...' NB: Birgit created a lot of stoichiometry definitions in the beginning before we realised this was a bad idea!

[To be discussed on Editor's call, then discussed with Birgit and Sandra again.]

Future plans

as discussed in a meeting with Birgit Meldal, Sandra Orchard, David Osumi-Sunderland and Paola Roncaglia on 28/4/2015

We discussed how we can make 'quick gains' in making the ontology more granular beyond the fixes Birgit does on a case by case basis. This is to target historic terms that have only 'protein complex' as a parent because they have no annotation extensions. The aim is to have most complexes grouped either by their function, location or subunit composition.

  • Do a pass through term names and definitions to find major groups of complexes that can be grouped by function, e.g. 'catalytic complex' (the term exists but many historic terms have not automatically been classified as such as they have no capable_of extensions). Other keywords: kinase, activity, viral, receptor, respiratory chain... [BM, SO & DOS]
  • Add parent terms based on location, such as 'membrane complex' and children or 'mitochondrial complex'. Can the reasoner place complexes automatically into this branch based on their part_of relationship (see above Rule 6)? Should we have a TG template for this? [BM, DOS]
  • Combine activity and location, such as 'membrane receptor complex'.
  • We discussed grouping by protein families but this may be tricky. Decide on a case by case basis. A working example are the BCL protein family complexes which cannot be grouped by function as they may be pro- and/or antiapoptotic.

Previous work

Emily started documentation here, in case it's helpful, but this wasn't worked on since 2011: http://wiki.geneontology.org/index.php/Protein_Complex_ids_as_GO_annotation_objects


Birgit's comments [from email to Paola]:

Inheritance of annotations: I agree with the wiki, you cannot inherit MF from a complex to a subunit and even a CC is problematic, see the transmembrane example above. This needs more thinking about. I don't know what you are doing right now...

Orthologies: We infer within taxon groups, e.g. human to mouse to rat or any other mammal etc, depending on where the exp evidence comes from. We systematically infer human-mouse. We have a few pombe complexes inferred from yeast (Sc!) but we don't do it systematically.

Paralogues: We make inferences between related complexes in the same species when the gene products are very similar, e.g. hemoglobin chains for adult and developmental complexes.

'Large' complexes: We have tackled the 'mediator' and we can now link to RNACentral for RNAs so time permitting we'll tackle the 'biggies' soon!

Pro: We have a list of Pro complexes that we consult for refs.

What IntAct is doing - a summary:

We didn't draw up an official set of rules but in summary this is what we do (and it pretty much matches what Paola says below and the wiki she cites): A complex should be taxon agnostic but may be restricted to certain taxonomic groups, such as pro- vs eukaryotes.

... should contain subunits in the def

... should have a 'as precise as possible' part_of relationship to the CC (may have to create new terms here as well of course!) which can be a complex (in cases of subcomplexes) or a location

... have, if possible, capable_of and capable_of_part_of annotation extensions.

... should have is_a relationship to an appropriate child term of 'protein complex'. This could be a term based on it's composition or function but NOT based on the PB. If no appropriate term exists, we create one based on either of the two classes. There is now a TG template for creating complex-by-MF which make curators' life much easier :) If there is no appropriate CC or complex-by-MF parent the new complex will be a direct child of 'protein complex'.

Useful links

IntAct Complex Portal, http://www.ebi.ac.uk/intact/complex/